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Veperfusion in Acute
yocardial Infarction
hould the Guidelines Be Modified?
e have read with great interest the manuscript written by Dieker
t al. (1) and the editorial by Jacobs and Hochberg (2) about the
elays in the pre-hospital phase of acute myocardial infarction. We
ppreciate the research in this still-unresolved subject. In the last
ecade there have been important improvements in the mechanical
eperfusion of acute myocardial infarction in terms of more potent
ntiplatelet therapy, better devices, development of system networks,
nd reduced in-hospital delays. However, as the authors state, there is
till a pending issue with pre-hospital delays in those patients whose
rst medical contact is in a hospital without percutaneous coronary
ntervention capability. We believe that the guidelines should address
n a more adequate manner the role and benefits of the pre-hospital
hrombolysis in the first 2 or 3 h and take into account that it might
e the preferable approach in certain scenarios. Previous randomized
tudies demonstrated that in the first 3 h the results of thrombolysis
nd primary angioplasty are comparable (3,4), but in the CAPTIM
Comparison of Angioplasty and Prehospital Thrombolysis in Acute
yocardial Infarction) trial after 5 years of follow-up (5) the patients
ncluded in the first 2 h showed a mortality of 5.8% with thrombolysis
nd 11.1% with primary angioplasty (hazard ratio: 0.50, 95% confi-
ence interval: 0.25 to 0.97, p 0.04). We believe that thrombolysis
ollowed by catheterization in 24 h might be a reasonable option in
ertain circumstances, such as when it is presumed that it will not be
ossible to achieve reperfusion in the desirable interval—especially in
he mentioned patients who need to be transferred to a different
ospital. In our opinion, the pre-hospital phase of the management of
cute myocardial infarction with primary angioplasty usually does not
eceive the same attention as whether there is a system of primary
ngioplasty. Programs of primary angioplasty are implemented—not
nusually in certain countries with public medical systems—without
n adequate system of transport, where the same ambulance is shared
ith other different, urgencies such as polytraumatisms or traffic
ccidents. We think that until this important and pending issue is
olved, thrombolysis in the ambulance should be considered an even
better option in the guidelines than primary angioplasty in the
entioned cases.
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re-Hospital Thrombolysis Rather
han Primary Percutaneous
ntervention Is the Treatment
f Choice for Patients With
T-Segment Elevation Myocardial
nfarction Presenting Early After
he Onset of Symptoms
ieker et al. (1) reported improved outcomes for patients with
T-segment elevation myocardial infarction (STEMI) who had
irect referral to an intervention center after ambulance-based
iagnosis and pre-hospital notification as compared to those
eferred through a nonintervention center. The results are not
urprising. The investigators, however, fail to discuss an alternative
reatment namely that of ambulance initiated pre-hospital throm-
olysis (PHT) with pre-notification and transport to an interven-
ion center followed by routine angiography and percutaneous
ntervention (PCI) if appropriate within 24 h of admission.
vailable evidence indicates that such an approach would yield
uperior results to those achieved in the field triage arm of their
tudy.
There has only been 1 randomized study of PHT versus primary
CI with long-term outcomes (2). In this study, patients random-
zed to receive ambulance-administered PHT within 2 h of onset
f symptoms had a substantially lower 5-year mortality than those
andomized to primary PCI (5.8% vs. 11.1%, p  0.04). Those
andomized between 2 and 4 h of symptoms had similar 5-year
ortality (14.5% vs. 14.4%). In support of these findings, the
iennese STEMI registry showed improved outcomes for throm-
olysis administered within 2 h after the onset of symptoms as
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Letters to the Editor1094ompared to primary PCI in this time frame (3). Importantly, in
his registry, only 14.6% of patients were able to receive primary
CI within 2 h of symptom onset, whereas 50.5% of patients were
ble to receive thrombolysis.
Irrespective of the method chosen, the aim of reperfusion is to
alvage myocardium and improve outcomes. A wealth of data
ndicates that reperfusion within 2 h of symptom onset results in
arkedly better outcomes than reperfusion at later intervals. Even
ith effective public education campaigns, it is likely that only a
mall minority of patients can ever receive primary PCI within 2 h
f the onset of symptoms, whereas a substantial proportion of
atients can receive PHT and achieve reperfusion within this time
rame. Rather than primary PCI for patients presenting early after
he onset of symptoms, ambulance-administered thrombolysis
ollowed by transport to a PCI capable hospital is the protocol that
hould be promoted.
Richard W. Harper, MBBS
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eply
ith interest we read the comments of Dr. Lozano and colleagues
nd Dr. Harper on the issue of reperfusion therapy for “pre-
ospitally” diagnosed ST-segment elevation myocardial infarction
atients presenting early after symptom onset. Although Dr.
arper suggests fibrinolysis with an early invasive strategy in all
re-hospital patients, Dr. Lozano and colleagues suggest this
trategy under “certain circumstances.” Our registry data show that
ith our strategy of pre-hospital diagnosis, catheter laboratory
otification from the ambulance, and direct transportation to an
ntervention center with optimal in-hospital logistics, primary
ngioplasty can be performed within 90 min of diagnosis in more
han 80% of patients. We acknowledge that pre-hospital and
n-hospital infrastructure varies per country and region, which
ight affect the preferred reperfusion therapy.
The current guidelines state that primary angioplasty is thenequivocally preferred reperfusion strategy, if it can be performedithin 90 min of presentation by an experienced team of personnel
1). The guidelines are based on the currently available evidence,
ncluding the CAPTIM (Comparison of Primary Angioplasty and
rehospital Fibrinolysis in Acute Myocardial Infarction Trial)
esults, and they do not make an exception for pre-hospital (or
arly) presenting patients. Dr. Harper’s statement that an early
re-hospital fibrinolytic strategy is superior to primary angioplasty
acks sufficient scientific evidence and therefore is not supported by
urrent guidelines. The remark that our results would have been
etter if a pre-hospital fibrinolytic strategy would have been used
nstead of primary angioplasty is presumptuous.
We agree with Dr. Lozano and colleagues that pre-hospital
brinolysis with a routine early invasive strategy is the preferred
eperfusion strategy under certain circumstances—namely if high-
uality primary angioplasty performed in a timely fashion is not
vailable. Our registry was initiated to monitor treatment delays in
rimary angioplasty. Before the initiation of primary angioplasty,
re-hospital fibrinolysis with a liberal rescue strategy has been
uccessfully used for more than 1 decade, with two-thirds of
atients being treated within 2 h of symptom onset. Our primary
ngioplasty data demonstrate that most patients are treated within
he time window of the guideline. Moreover, we show that
uideline adherence can be substantially improved if all patients are
eferred directly to an intervention center instead of through a
onintervention center.
We concur with both authors that the impact of (early)
re-hospital fibrinolysis with an early invasive strategy in patients
t low risk of bleeding might be underestimated, and this strategy
eserves further study. To date, the CAPTIM study is the only
vailable randomized trial in the pre-hospital setting comparing
oth reperfusion strategies in the optimal setting. The suggested
uperiority of early fibrinolysis stems from a subgroup analysis of a
rematurely discontinued, overall neutral trial, and these results
hould be interpreted with caution. The currently enrolling
TREAM (Strategic Reperfusion Early After Myocardial Infarc-
ion) trial compares both reperfusion strategies in patients present-
ng within 3 h of symptom onset, and results are eagerly awaited.
t least until then, timely high-quality primary angioplasty re-
ains the treatment of preference.
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